Previously proposed staging systems for HCC include the Barcelona Clinical Liver Cancer (BCLC) staging [3], Cancer of the Liver Italian Program (CLIP) score [4], Japan Integrated Staging (JIS) [5], and Albumin–Bilirubin-TNM of the Liver Cancer Study Group of Japan 6th edition (LCSGJ 6th) (ALBI-T) score [6]. This evidence concerns the gene ALB and liver cancer.